アジア太平洋のMRD検査市場：分析と予測（2023年～2033年）

アジア太平洋のMRD（微小残存病変）検査の市場規模は、2023年の3億米ドルから2033年には13億3,000万米ドルに達し、予測期間の2023年～2033年のCAGRは16.06%になると予測されています。

MRD検査市場は、MRD検査に対するメディケアの適用範囲拡大や固形がんの診断への応用など、いくつかの理由によって拡大しています。消費者の意識の高まりにより、MRD検査の需要が高まっています。ヘルスケア従事者や研究者はこの動向を認識し、患者のニーズに対応するためにMRD検査を臨床に組み込もうとしています。

アジア太平洋のMRD検査市場は、さまざまな要因によって大きな成長を遂げています。これには、MRD検査のヘルスケア適用範囲の拡大や、固形がんの診断におけるMRD検査の新たな役割が含まれます。消費者の間でMRD検査に対する認識が高まっていることが、同地域全体でのMRD検査需要の急増につながっています。ヘルスケア専門家や研究者はこの動向を認識し、患者のニーズを効果的に満たすためにMRD検査を日常的な臨床処置に組み込むことに積極的に取り組んでいます。さらに、APACの主要国におけるテクノロジーとヘルスケアインフラの進歩は、MRD検査市場の拡大にさらに貢献しています。早期発見と精密医療に重点が置かれつつあるAPAC地域は、MRD検査プロバイダーと利害関係者にとって大きなビジネスチャンスです。

当レポートでは、アジア太平洋のMRD検査市場について調査し、市場の概要とともに、エンドユーザー別、国別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

エグゼクティブサマリー

第1章 市場

• 市場範囲
• 調査手法
• 市場推定モデル

第2章 市場概要

• MRD検査のワークフロー分析
• MRD検査：固形腫瘍vs血液悪性腫瘍
• MRD検査の進化
• 市場フットプリント
• 市場規模と今後の成長可能性

第3章 業界考察

• MRD検査の法的および規制の枠組み
• 償還シナリオ
• サプライチェーン分析
  • ラボ開発テスト（LDT）用
  • 体外診断（IVD）用

第4章 MRD検査市場（地域別）、2022年～2033年

• 概要
• アジア太平洋
  • アジア太平洋のMRD検査市場、エンドユーザー別
  • アジア太平洋のMRD検査市場、国別

第5章 企業プロファイル

• Sysmex Corporation

List of Figures

• Figure 1: Asia-Pacific MRD Testing Market, $Billion, 2022 and 2033
• Figure 2: Share of Asia-Pacific MRD Testing Market (by End User), $Billion, 2022 and 2033
• Figure 3: Share of MRD Testing Market (by Region), 2022
• Figure 4: MRD Testing Market: Research Methodology
• Figure 5: Primary Research Methodology
• Figure 6: Bottom-Up Approach (Segment-Wise Analysis)
• Figure 7: Top-Down Approach (Segment-Wise Analysis)
• Figure 8: MRD Testing Workflow
• Figure 9: Evolution of the MRD Testing Market
• Figure 10: Asia-Pacific MRD Testing Market Potential, $Billion, 2022-2033
• Figure 11: Supply Chain Analysis of Laboratory-Developed Tests
• Figure 12: Supply Chain Analysis of In-Vitro Diagnostics
• Figure 13: MRD Testing Market Snapshot (by Region)
• Figure 14: Asia-Pacific: Market Dynamics
• Figure 15: Asia-Pacific MRD Testing Market, $Billion, 2022-2033
• Figure 16: Asia-Pacific MRD Testing Market (by End User), $Million, 2022-2033
• Figure 17: Asia-Pacific MRD Testing Market (by Country), $Million, 2022-2033
• Figure 18: China MRD Testing Market, $Million, 2022-2033
• Figure 19: India MRD Testing Market, $Million, 2022-2033
• Figure 20: Japan MRD Testing Market, $Million, 2022-2033
• Figure 21: South Korea MRD Testing Market, $Million, 2022-2033
• Figure 22: Australia MRD Testing Market, $Million, 2022-2033
• Figure 23: Singapore MRD Testing Market, $Million, 2022-2033
• Figure 24: Rest-of-Asia-Pacific MRD Testing Market, $Million, 2022-2033
• Figure 25: MRD Testing Market, Total Number of Companies Profiled
• Figure 26: Sysmex Corporation: Product Portfolio
• Figure 27: Sysmex Corporation: Overall Financials, $Million, 2020-2022
• Figure 28: Sysmex Corporation: Revenue (by Segment), $Million, 2020-2022
• Figure 29: Sysmex Corporation: Revenue (by Region), $Million, 2020-2022
• Figure 30: Sysmex Corporation: R&D Expenditure, $Million, 2020-2022

List of Tables

• Table 1: Impact Analysis of Market Drivers, Challenges, and Opportunities in the MRD Testing Market
• Table 2: Comparison of Solid Tumor and Hematological Malignancy for MRD Testing
• Table 3: Registration Criteria for IVD Medical Devices as per CFDA

The Asia-Pacific MRD Testing Market Expected to Reach $1.33 Billion by 2033

Introduction to Asia-Pacific MRD Testing Market

The Asia-Pacific MRD testing market is projected to reach $1.33 billion by 2033 from $0.30 billion in 2023, growing at a CAGR of 16.06% during the forecast period 2023-2033. The MRD testing market is expanding due to several reasons, including the expansion of Medicare coverage for MRD testing and its application in diagnosing solid tumors. Increased consumer awareness has led to a heightened demand for MRD testing. Healthcare practitioners and researchers are recognizing this trend and endeavouring to integrate MRD testing into clinical practices to address patient needs.

Market Introduction

The Asia-Pacific (APAC) MRD testing market is witnessing significant growth driven by various factors. This includes the extension of healthcare coverage for MRD testing and its emerging role in diagnosing solid tumors. Increasing awareness among consumers has led to a surge in demand for MRD testing across the region. Healthcare professionals and researchers are recognizing this trend and actively working to incorporate MRD testing into routine clinical procedures to meet patient needs effectively. Additionally, advancements in technology and healthcare infrastructure in key APAC countries further contribute to the expansion of the MRD testing market. With a growing emphasis on early detection and precision medicine, the APAC region presents substantial opportunities for MRD testing providers and stakeholders.

Market Segmentation:

Segmentation 1: by End User

• Hospitals and Speciality Clinics
• Research Institutions
• Diagnostic Laboratories
• Other End Users

Segmentation 2: by Country

• China
• India
• Japan
• South Korea
• Australia
• Singapore
• Rest-of-Asia-Pacific

How Can This Report Add Value to an Organization?

Growth/Marketing Strategy: The APAC MRD testing market has seen major development by key players operating in the market, such as business expansion, partnership, collaboration, and joint venture. The favored strategy for the companies has been partnerships and collaborations to strengthen their position in the MRD testing market.

Competitive Strategy: Key players in the APAC MRD testing market analyzed and profiled in the study involve major residual testing-based companies and test manufacturers. Moreover, a detailed competitive benchmarking of the players operating in the APAC MRD testing market has been done to help the reader understand how players stack against each other, presenting a clear market landscape. Additionally, comprehensive competitive strategies such as partnerships, agreements, and collaborations will aid the reader in understanding the untapped revenue pockets in the market.

Table of Contents

Executive Summary

1 Markets

• 1.1 Market Scope
  • 1.1.1 Key Questions Answered in the Report
• 1.2 Research Methodology
  • 1.2.1 MRD Testing Market: Research Methodology
  • 1.2.2 Data Sources
• 1.3 Market Estimation Model
  • 1.3.1 Criteria for Company Profiling

2 Market Overview

• 2.1 MRD Testing Workflow Analysis
• 2.2 MRD Testing: Solid Tumor vs. Hematological Malignancy
• 2.3 Evolution of MRD Testing
• 2.4 Market Footprint
• 2.5 Market Size and Future Growth Potential

3 Industry Insights

• 3.1 Legal and Regulatory Framework of MRD Tests
  • 3.1.1 Asia-Pacific
• 3.2 Reimbursement Scenario
  • 3.2.1 Asia-Pacific
• 3.3 Supply Chain Analysis
  • 3.3.1 For Laboratory Developed Tests (LDTs)
  • 3.3.2 For In-Vitro Diagnostics (IVDs)

4 Minimal Residual Disease Testing Market (by Region), 2022-2033

• 4.1 Overview
• 4.2 Asia-Pacific
  • 4.2.1 Asia-Pacific MRD Testing Market, by End User
  • 4.2.2 Asia-Pacific MRD Testing Market, by Country

5 Company Profiles

• 5.1 Overview
• 5.2 Sysmex Corporation
  • 5.2.1 Company Overview
  • 5.2.2 Role of Sysmex Corporation in the MRD Testing Market
  • 5.2.3 Financials
  • 5.2.4 Analyst Perspective